Octapharma Group And Fresenius Kabi Enter Into An Exclusive License, Development 29th October 2009 - Views: 1911 Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation(R) Technology to develop a HESylated recombinant protein.
Csl Donates 3 Million Doses Of Pandemic H1n1 2009 Vaccine To The World Health Organisation (who) For 15th October 2009 - Views: 1362 CSL Limited, Australia's leading biopharmaceutical company, has todayannounced that it is donating 3 million doses of pandemic H1N1 2009 or `swineflu' vaccine to the World Health Organisation for use in priority low-incomecountries in the South Pacific as well as South East Asia.
New Technology Set To Increase Mobility For People Who Are Blind 14th October 2009 - Views: 1767 Talking GPS guides, hand-held devices that emit ultra-sonic beams, and canes in different sizes and colours. These are the tools now being used by people with impaired vision to stay active, mobile and independent.
A Swiss Team Uses Transcranial Mr-guided Focused Ultrasound To Treat Patients W 14th July 2009 - Views: 1552 InSightec Ltd. today announced that a team at the University Children's Hospital Zurich has completed a feasibility study testing the use of non-invasive transcranial MR-guided focused ultrasound surgery (MRgFUS) for the treatment of neuropathic pain.
Living Cell Technologies' Diabetes Clinical Trial Authorized By New Zealand Government 25th June 2009 - Views: 1457 Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that the New Zealand Minister of Health, the Honourable Tony Ryall, has authorized LCT's New Zealand Phase I/IIa clinical trial of DIABECELL® for insulin dependent diabetes.